Evidence mapPaperPMID 37571297Full record

Trial reportNutrients2023

Effect of a 12-Week Polyphenol Rutin Intervention on Markers of Pancreatic β-Cell Function and Gut Microbiota in Adults with Overweight without Diabetes.

Akarsh Mathrani, Wilson Yip, Ivana R Sequeira-Bisson, Daniel Barnett, Oliver Stevenson, Michael W Taylor, Sally D Poppitt

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Rutin: a pain-relieving flavonoid.Inflammopharmacology · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Akarsh MathraniSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0003-2240-6960
Wilson YipSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.
Ivana R Sequeira-BissonSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0001-5414-9925
Daniel BarnettDepartment of Statistics, University of Auckland, Auckland 1010, New Zealand.
Oliver StevensonDepartment of Statistics, University of Auckland, Auckland 1010, New Zealand.
Michael W TaylorSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.
Sally D PoppittSchool of Biological Sciences, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-2214-8378
University of Auckland · NZ

Funding

High-Value Nutrition National Science Challenge, New Zealand 3710040Maurice Wilkins Centre Flexible Research Programme 3713851
6 · The paper itself

Abstract

Supplementation with prebiotic polyphenol rutin is a potential dietary therapy for type 2 diabetes prevention in adults with obesity, based on previous glycaemic improvement in transgenic mouse models. Gut microbiota are hypothesised to underpin these effects. We investigated the effect of rutin supplementation on pancreatic β-cell function measured as C-peptide/glucose ratio, and 16S rRNA gene-based gut microbiota profiles, in a cohort of individuals with overweight plus normoglycaemia or prediabetes. Eighty-seven participants were enrolled, aged 18-65 years with BMI of 23-35 kg/m

Indexed as

Gastrointestinal MicrobiomePrediabetic StateRutinAdolescentAdultAgedHumansMiddle AgedObesityOverweightPolyphenolsYoung AdultPolyphenolsRutingut microbiotapancreas β-cell functionprebiotic polyphenol rutin

Identifiers

PMID37571297
PMCPMC10420824
OpenAlexW4385423053

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.